1  Consideration should be given to developing additional safeguards against ICU errors, particularly d

2  enhancing the safety of these products, but additional safeguards could be implemented, and unlike d

3 ocess; procedures used operationally include additional safeguards designed to minimize errors.

4  as well as laws in some states that provide additional safeguards for genetic data, should reassure

5 ure or prohibition of conflicts of interest, additional safeguards for sensitive medical conditions,

6 e other major U.S. groups have also proposed additional safeguards for this population, and existing

7  vulnerable to reconstruction, implying that additional safeguards may need to be considered.

8 s circumvented, kappa editing and anergy are additional safeguards preventing 2F5 V(H)/V(L) expressio

9 ith geminin, whereas noncancer cells contain additional safeguards that prevent DNA re-replication.

10 before sprouting and reinforces the need for additional safeguards to protect the public.